DM Clinical Research
@dmclinical.com
DM Clinical Research is the largest privately owned clinical research site network in the country, 30+ sites, 13 states, 85+ conditions across 13 therapeutic areas, 1.97M+ patient database. Built for sponsors and CROs who need faster enrollment and reliable, accountable site performance.
DM Clinical Research's Company Logos


DM Clinical Research's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#A8A9AB
Aluminium
168, 169, 171
220, 2, 66
2, 1, 0, 33
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#134563
Chathams Blue
19, 69, 99
203, 68, 23
81, 30, 0, 61
About DM Clinical Research
DM Clinical Research is a privately owned clinical research site network operating since 2006. With more than 30 integrated sites across 13 states, the organization conducts clinical trials from Phase I through Phase IV, covering more than 85 conditions across 13 therapeutic areas. Its services support sponsors and contract research organizations (CROs), as well as physicians, healthcare partners, and people seeking clinical trials.
For sponsors and CROs, DM Clinical Research offers site-level feasibility, enrollment forecasting, centralized study startup support, and coordinated trial execution under a shared operating model. Its network-wide operations include standardized procedures, regulatory and contracting support, and central quality oversight. Recruitment resources include a database of more than 1.97 million patients, enrollment specialists, bilingual English- and Spanish-language engagement, and community and physician relationships. Investigators conduct studies across the network, while practices and health systems can partner with DM to offer research opportunities to patients. The organization also guides prospective participants to available studies through a dedicated trial website, with bilingual support.
Company type
Privately Held
Year founded
2006
Company size
501-1000 employees
Related Brands
Tags
Clinical trial participant recruitment
Phase I–IV clinical trials
Clinical research investigator sites
Multitherapeutic therapeutic areas
